This observation does not corroborate other studies performed in CRC using NOS2 as a marker, in which ~60% of the overall tumor macrophages were considered pro-inflammatory (23), but again we argue that this might not be an ideal pro-inflammatory marker of human macrophages. This evidence concerns the gene NOS2 and colorectal carcinoma.